Memorial Sloan Kettering Cancer Center
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
Active, not recruiting
- Conditions
- GlioblastomaBrain Cancer
- Interventions
- Behavioral: psychometric tests, questionnaires and neurocognitive assessments
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 309
- Registration Number
- NCT02375841
- Locations
- πΊπΈ
Henry Ford Hospital, Detroit, Michigan, United States
πΊπΈMemorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
πΊπΈMemorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Testing a Personalize Medication Log for Patients With Lymphoma
Completed
- Conditions
- Lymphoma
- Interventions
- Other: personalized medication logOther: standard of careBehavioral: questionnairesBehavioral: Cognitive Interview
- First Posted Date
- 2015-02-25
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT02370446
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
Active, not recruiting
- Conditions
- Lynch SyndromeHereditary Colonic Polyposis Syndromes
- Interventions
- Genetic: colonic biopsiesGenetic: questionnaires
- First Posted Date
- 2015-02-25
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 77
- Registration Number
- NCT02371135
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients
Not Applicable
Completed
- Conditions
- Breast CancerPeripheral Neuropathy
- Interventions
- Procedure: AcupunctureBehavioral: Neuropathic Pain Scale (NPS) questionnaireBehavioral: FACT/GOG-Ntx questionnaire
- First Posted Date
- 2015-02-18
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT02364726
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
πΊπΈMemorial Sloan Kettering Westchester, Harrison, New York, United States
Genomic Predictors of Papillary Microcarcinoma Disease Progression
Recruiting
- Conditions
- Papillary Microcarcinoma
- First Posted Date
- 2015-02-16
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 500
- Registration Number
- NCT02363595
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Animal Assisted Activity Program on Patients and Staff on an Inpatient Surgical Oncology Unit
Completed
- Conditions
- Postoperative Care
- Interventions
- Other: standard post surgery careBehavioral: Caring Canine programBehavioral: baseline and post assessment
- First Posted Date
- 2015-02-16
- Last Posted Date
- 2017-01-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 146
- Registration Number
- NCT02363608
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant
Not Applicable
Terminated
- Conditions
- Non-Hodgkin's LymphomaLeukemiaMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2015-02-10
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT02360111
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial
- Conditions
- Neuroendocrine Tumors
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT02358018
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy
Not Applicable
Completed
- Conditions
- InsomniaCancer
- Interventions
- Other: AcupunctureOther: Cognitive Behavior Therapy
- First Posted Date
- 2015-02-05
- Last Posted Date
- 2022-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 160
- Registration Number
- NCT02356575
- Locations
- πΊπΈ
Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States
πΊπΈMemorial Sloan Kettering Cancer Center, New York, New York, United States
Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs
Phase 2
Completed
- Conditions
- Advanced Stage Non-small Cell Lung Cancer
- Interventions
- Drug: pilimumab
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT02350764
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States